TWiV 761: COVID-19 clinical update #64 with Dr. Daniel Griffin

May 29, 2021

In COVID-19 clinical update #64, Daniel Griffin covers new guidance from NY on day camps, mitigation and infection rates in schools, testing to sustain in person instruction, Moderna mRNA vaccine highly effective in adolescents, longer storage of Pfizer vaccine, FDA EUA for sotrovimab, and persistent illness in UK children.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 761 (25 MB .mp3, 41 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 761: COVID-19 clinical update #64 with Dr. Daniel Griffin

  1. March 4, 2021
    Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
    A Randomized Clinical Trial
    JAMA. 2021;325(14):1426-1435. doi:10.1001/jama.2021.3071
    Ivermectin, ‘Wonder drug’ from Japan: the human use perspective
    Proc Jpn Acad Ser B Phys Biol Sci. 2011 Feb 10; 87(2): 13–28.
    doi: 10.2183/pjab.87.13

    Ivermectin, the wonder drug / silver bullet of the third world found in a soil sample from Japan, originally produced for animal use, now widely used in many, esp. parasitic infections, but intriguing because mechanism of action not truly understood! despite our broad reliance on it, but appears to alter molecular biology of the microcritter so that it is less evasive of immune system, thus hard for it to develop drug resistance. …SO we hope based not on data but perversely,on ignorance.

  2. How many classrooms have windows that can be opened at least partially ?
    Can you test how well a class room is ventilated by particles of Covid per room or other measure ?
    Monoclonal Antibodies only seem available in the USA .
    Can they be exported or can other lands produce them ?